CareDx, Inc. cotiza a 65.43 USD y tiene una capitalización bursátil de $3.4B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally. The company provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression profiling solution …
| Periodo | 2026-11 | 2026-07 | 2026-04 | 2026-02 |
|---|---|---|---|---|
| Real | — | $0.37 | $0.34 | $0.12 |
| Estimado | $0.26 | $0.23 | $0.13 | $0.23 |
| Sorpresa | — | +60.9% | +161.5% | -47.8% |
| Métrica | CDNA | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -8.1% | -38.6% | +30.5% |
| Net Margin | -5.6% | -33.6% | +27.9% |
| FCF Margin | — | -13.9% | — |
| ROE | -7.0% | -40.4% | +33.4% |
| ROA | -5.2% | -32.0% | +26.8% |
| Current Ratio | 2.86 | 2.84 | +0.02 |
| Debt / Equity | — | 0.28 | — |